Press release
Heart Failure Drugs Market Size to Boost USD 21.63 Billion By 2032 | CAGR 5.9% Published by Emergen Research
Heart Failure Drugs Market
The heart failure drugs market plays a critical role in managing a condition that affects millions of people worldwide. Heart failure, a chronic condition where the heart is unable to pump blood efficiently, often results from underlying cardiovascular issues such as coronary artery disease, high blood pressure, or diabetes. The global market for heart failure drugs has grown significantly in response to the rising prevalence of heart failure, an aging population, and advancements in therapeutic options. This market consists of various drug classes, including ACE inhibitors, beta-blockers, diuretics, and more recently developed angiotensin receptor-neprilysin inhibitors (ARNIs) and sodium-glucose co-transporter-2 (SGLT2) inhibitors. These medications are designed to improve the heart's function, manage symptoms, and reduce the likelihood of hospitalization or death due to heart failure.
The report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. The crisis has affected the demand and supply pattern, as well as the trends of the industry. It has also brought an economic slowdown that has affected the business of the key manufacturers of the industry. The report estimates the impact of this crisis on the current scenario and future prospects and provides a post-COVID market scenario.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2755
Drivers of the Heart Failure Drugs Market :
Several factors are driving the growth of the heart failure drugs market. The most prominent driver is the increasing global prevalence of heart failure. As the population ages, the incidence of cardiovascular diseases rises, leading to a higher number of heart failure cases. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death worldwide, accounting for nearly 18 million deaths annually. Heart failure is a significant contributor to this burden, thus fueling the demand for effective therapeutic interventions.
Additionally, the market is being driven by advances in pharmaceutical research and development. The introduction of new drug classes, such as ARNIs and SGLT2 inhibitors, has revolutionized the treatment landscape, providing more effective solutions for patients. These drugs not only help to manage the symptoms of heart failure but also improve patient outcomes by reducing hospitalizations and mortality rates. Furthermore, rising awareness among healthcare professionals and patients about the importance of early diagnosis and treatment has also contributed to market growth.
Restraints of the Heart Failure Drugs Market :
Despite its growth potential, the heart failure drugs market faces several restraints. One of the primary challenges is the high cost associated with new and innovative therapies. While newer drugs have demonstrated superior efficacy, their high prices can limit access for patients, particularly in low-income regions. Additionally, the need for long-term medication in heart failure patients means that treatment costs can accumulate over time, creating a financial burden for healthcare systems and individuals.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2755
Growth Factors of the Heart Failure Drugs Market :
The heart failure drugs market is poised for further growth due to several favorable factors. One of the most significant growth drivers is the increasing investment in cardiovascular research and drug development. Pharmaceutical companies are focusing on developing novel therapies that target specific pathways involved in heart failure, providing more personalized and effective treatment options. The approval of innovative drugs like Entresto (sacubitril/valsartan) and Farxiga (dapagliflozin) has opened new avenues for the treatment of heart failure, especially for patients with reduced ejection fraction.
The report also discusses the key players involved in the market such as:
Amgen Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Bausch Health Companies Inc., Cardurion Pharmaceuticals, Cardior Pharmaceuticals GmbH, CYTOKINETICS, INC., Janssen Global Services, LLC, Lilly, Exelixis, Inc., Gilead Sciences, Inc., GSK plc, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd
The report provides a thorough estimation of the overall impact of the pandemic on the Heart Failure Drugs Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Heart Failure Drugs Market
Heart Failure Drugs Market Segment Analysis :
For the purpose of this report, Emergen Research has segmented global heart failure drugs market on the basis of type, application, stage of heart failure, distribution channel, end-use, and region:
Type Outlook (Revenue, USD Billion; 2019-2032)
Beta Blockers
ACE Inhibitors
Angiotensin-receptor neprilysin inhibitors
Angiotensin receptor blockers
Diuretics
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Injection
Capsule
Tablets
Others
Stage Of Heart Failure Outlook (Revenue, USD Billion; 2019-2032)
Acute
Chronic
Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Specialty Centers
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/heart-failure-drugs-market
Explore More of this reports @
Heart Failure Drugs Market Size @ https://www.emergenresearch.com/industry-report/heart-failure-drugs-market/market-size
Heart Failure Drugs Market Share @ https://www.emergenresearch.com/industry-report/heart-failure-drugs-market/market-share
Heart Failure Drugs Market Trends @ https://www.emergenresearch.com/industry-report/heart-failure-drugs-market/market-trends
Heart Failure Drugs Regional Market Demand @ https://www.emergenresearch.com/industry-report/heart-failure-drugs-market/regional-market-demand
Heart Failure Drugs Market Analysis @ https://www.emergenresearch.com/industry-report/heart-failure-drugs-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure Drugs Market Size to Boost USD 21.63 Billion By 2032 | CAGR 5.9% Published by Emergen Research here
News-ID: 3684072 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
